Viewing nowCombinationEmpagliflozin/Metformin Extended-Release Tablet 10/1000 mg (Empagliflozin, Metformin)
Empagliflozin 10mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.

MFDS item code 202501909 · Approved 2025.07.25 · Insurance code 647805930
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to assist in blood glucose control in adults with type 2 diabetes through the combination of empagliflozin and metformin. It is particularly suitable for patients on diet and exercise regimens, and is administered when blood glucose control is difficult. Additionally, the effects of this medication on the occurrence of cardiovascular events in adults with type 2 diabetes who have cardiovascular disease should be consulted according to professional guidelines. Therefore, it helps in the management of blood glucose and cardiovascular health in diabetic patients with concurrent cardiovascular disease.
For antidiabetic therapy, the dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25mg and metformin hydrochloride extended-release 2000 mg. To reduce gastrointestinal adverse reactions caused by metformin, take this medicine once daily with the evening meal. Take one tablet of this medicine 10/1000 mg extended-release tablet or 25/1000 mg extended-release tablet once daily. Patients taking this medicine 5/1000 mg extended-release tablet or 12.5/1000 mg extended-release tablet should take 2 tablets together once daily. To reduce gastrointestinal adverse reactions associated with metformin use, the dose of metformin hydrochloride should be increased gradually. To maintain its extended-release properties, swallow this medicine whole without splitting, crushing, grinding, or chewing. This medicine may not dissolve completely and may be excreted in the feces. It is not known whether the material excreted in the feces contains the active ingredient of the medicine. If a patient repeatedly reports finding this medicine in their feces, healthcare professionals should assess whether blood glucose is being adequately controlled (see Precautions for Use, 5. General precautions). ⦁ For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended initial total daily dose when taking this medicine is empagliflozin 10 mg plus the patient's current metformin dose. If empagliflozin 10 mg is well tolerated but additional glycemic control is needed, the dose of empagliflozin may be increased to 25 mg. ⦁ Patients switching from concomitant empagliflozin and metformin therapy to this medicine should receive their previous doses of empagliflozin and metformin. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose appropriately adjusted. ⦁ When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse reactions and 6. Interactions). Special populations Renal impairment Because dosage adjustment is required according to renal function, assessment of renal function is recommended before starting this medicine and periodically during treatment. No dosage adjustment is necessary in patients with mild renal impairment [creatinine clearance (CrCl) ≧ 60 mL/min or estimated glomerular filtration rate (eGFR) ≧ 60 mL/min/1.73 m2]. In patients with moderate renal impairment [CKD stage 3A, creatinine clearance (CrCl) ≧ 45 mL/min and <60mL/min or estimated glomerular filtration rate (eGFR) ≧ 45 mL/min/1.73m2 and <60mL/min/1.73m2] who tolerate treatment well and have no other condition that may increase the risk of lactic acidosis, this medicine may be used with adjustment of the metformin hydrochloride dose as follows. - The starting dose of extended-release metformin hydrochloride is 500 mg or 750 mg once daily; therefore, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000mg. If creatinine clearance (CrCl) decreases to below 45 ml/min or estimated glomerular filtration rate (eGFR) decreases to below 45 ml/min/1.73m2, discontinue this medicine immediately. Older adults In patients 75 years of age and older, consider renal function and the risk of volume depletion.
This medication helps control blood glucose and is used for diabetes treatment. Before taking this medication, renal function must be confirmed to be normal; it should not be used in cases of severe renal impairment. This medication should also not be used in cases of severe infections, dehydration, acute heart problems, or acute illnesses such as sepsis. This medication can cause a rare side effect known as lactic acidosis, which can be life-threatening; if symptoms such as vomiting, abdominal pain, difficulty breathing, or weakness occur, consult a physician immediately. Furthermore, when this medication is used in combination with other diabetes medications, there may be an increased risk of hypoglycemia, so blood glucose changes should be closely monitored. Temporarily discontinue this medication before and after procedures or tests involving iodinated contrast media, and resume only after renal function has fully recovered. This medication may increase the risk of genital infections and urinary tract infections, so treatment should be sought immediately upon the onset of infection symptoms. Elderly patients or those at risk of fluid loss should be particularly cautious of dehydration or hypotension while taking this medication and it is important to regularly monitor renal function. Women who are pregnant, potentially pregnant, or breastfeeding should avoid this medication, and breastfeeding should be discontinued while taking it. This medication should be swallowed whole without breaking or chewing the tablets; while the coating may appear in stools, this is normal. Alcohol consumption should be avoided during treatment, and any concurrent medications should be consulted with a physician or pharmacist due to potential interactions. Symptoms of hypoglycemia, such as dizziness, cold sweat, or trembling, may occur while taking this medication; recognize and respond appropriately to these symptoms. In case of overdose, seek medical attention immediately for appropriate treatment, particularly because of the risk of lactic acidosis requiring prompt action. This medication should be stored safely and kept out of reach of children.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to prevent exposure to air or moisture, and maintain the storage temperature between 1 to 30 degrees Celsius. Proper storage can prolong the effectiveness of the medication.
Dark yellow oval extended-release film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 10mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.